However, HR+ breast cancer is generally characterized by a "cold" immune phenotype with low tumor-infiltrating lymphocytes and limited PD-L1 expression, contributing to the relatively poor responsiveness to ICIs observed in this subtype16, 17. Here, CD274 is linked to neoplasm.